CN Patent

CN105125539A — 吡格列酮二甲双胍片及其制备方法

Assigned to Zhejiang Huahai Pharmaceutical Co Ltd · Expires 2015-12-09 · 10y expired

What this patent protects

本发明公开了一种吡格列酮二甲双胍片剂及其制备方法，其中该片剂由盐酸二甲双胍颗粒与盐酸吡格列酮以及药学上可接受的辅料组成，其中盐酸二甲双胍颗粒是盐酸二甲双胍单独或与药学上可接受的辅料一起制粒后得到的。本发明得到的片剂能快速溶出，含量均匀度良好，且制备步骤简单，利于工业化生产。

USPTO Abstract

本发明公开了一种吡格列酮二甲双胍片剂及其制备方法，其中该片剂由盐酸二甲双胍颗粒与盐酸吡格列酮以及药学上可接受的辅料组成，其中盐酸二甲双胍颗粒是盐酸二甲双胍单独或与药学上可接受的辅料一起制粒后得到的。本发明得到的片剂能快速溶出，含量均匀度良好，且制备步骤简单，利于工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN105125539A
Jurisdiction
CN
Classification
—
Expires
2015-12-09
Drug substance claim
No
Drug product claim
No
Assignee
Zhejiang Huahai Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.